These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 3468634
1. Expression of mouse dihydrofolate reductase gene confers methotrexate resistance in transgenic petunia plants. Eichholtz DA, Rogers SG, Horsch RB, Klee HJ, Hayford M, Hoffmann NL, Braford SB, Fink C, Flick J, O'Connell KM. Somat Cell Mol Genet; 1987 Jan; 13(1):67-76. PubMed ID: 3468634 [Abstract] [Full Text] [Related]
3. Construction of a new vector conferring methotrexate resistance in Nicotiana tabacum plants. Irdani T, Bogani P, Mengoni A, Mastromei G, Buiatti M. Plant Mol Biol; 1998 Aug; 37(6):1079-84. PubMed ID: 9700079 [Abstract] [Full Text] [Related]
4. Comparison of cauliflower mosaic virus 35S and nopaline synthase promoters in transgenic plants. Sanders PR, Winter JA, Barnason AR, Rogers SG, Fraley RT. Nucleic Acids Res; 1987 Feb 25; 15(4):1543-58. PubMed ID: 3029718 [Abstract] [Full Text] [Related]
5. Expression of mouse metallothionein-I gene confers cadmium resistance in transgenic tobacco plants. Pan A, Yang M, Tie F, Li L, Chen Z, Ru B. Plant Mol Biol; 1994 Jan 25; 24(2):341-51. PubMed ID: 8111036 [Abstract] [Full Text] [Related]
6. Seed-transmissible expression of mammalian metallothionein in transgenic tobacco. Maiti IB, Hunt AG, Wagner GJ. Biochem Biophys Res Commun; 1988 Jan 29; 150(2):640-7. PubMed ID: 2829879 [Abstract] [Full Text] [Related]
7. Phleomycin resistance as a dominant selectable marker for plant cell transformation. Perez P, Tiraby G, Kallerhoff J, Perret J. Plant Mol Biol; 1989 Oct 29; 13(4):365-73. PubMed ID: 2485087 [Abstract] [Full Text] [Related]
8. Methotrexate is a new selectable marker for tobacco immature pollen transformation. Aionesei T, Hosp J, Voronin V, Heberle-Bors E, Touraev A. Plant Cell Rep; 2006 May 29; 25(5):410-6. PubMed ID: 16331457 [Abstract] [Full Text] [Related]
9. Construction and use of a dominant, selectable marker: a Harvey sarcoma virus-dihydrofolate reductase chimera. Murray MJ, Kaufman RJ, Latt SA, Weinberg RA. Mol Cell Biol; 1983 Jan 29; 3(1):32-43. PubMed ID: 6298606 [Abstract] [Full Text] [Related]
10. Systemic resistance to methotrexate in transgenic mice carrying a mutant dihydrofolate reductase gene. Isola LM, Gordon JW. Proc Natl Acad Sci U S A; 1986 Dec 29; 83(24):9621-5. PubMed ID: 3467329 [Abstract] [Full Text] [Related]
11. [Transformation of mice by a prokaryotic gene for dihydrofolate reductase]. Titomirov AV, Aprelikova ON, Vaĭsman BL, Tomilin NV. Tsitologiia; 1985 Dec 29; 27(12):1374-9. PubMed ID: 3003983 [Abstract] [Full Text] [Related]
12. Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate. Vinh DB, McIvor RS. J Pharmacol Exp Ther; 1993 Nov 29; 267(2):989-96. PubMed ID: 8246174 [Abstract] [Full Text] [Related]
13. Expression of a methotrexate resistant dihydrofolate reductase gene in transgenic mice. Isola LM, Gordon JW. Dev Genet; 1989 Nov 29; 10(5):349-55. PubMed ID: 2480860 [Abstract] [Full Text] [Related]
14. Vectors containing a prokaryotic dihydrofolate reductase gene transform Drosophila cells to methotrexate-resistance. Bourouis M, Jarry B. EMBO J; 1983 Nov 29; 2(7):1099-104. PubMed ID: 6194991 [Abstract] [Full Text] [Related]
15. Transfection of DHFR- and DHFR+ mammalian cells using methotrexate-resistant mutants of mouse dihydrofolate reductase. Thillet J, Pictet R. FEBS Lett; 1990 Sep 03; 269(2):450-3. PubMed ID: 2401371 [Abstract] [Full Text] [Related]
16. Expression of a methotrexate-resistant dihydrofolate reductase gene by transformed hematopoietic cells of mice. Bar-Eli M, Stang HD, Mercola KE, Cline MJ. Somatic Cell Genet; 1983 Jan 03; 9(1):55-67. PubMed ID: 6836451 [Abstract] [Full Text] [Related]
17. Transformation of mouse fibroblasts to methotrexate resistance by a recombinant plasmid expressing a prokaryotic dihydrofolate reductase. O'Hare K, Benoist C, Breathnach R. Proc Natl Acad Sci U S A; 1981 Mar 03; 78(3):1527-31. PubMed ID: 6262811 [Abstract] [Full Text] [Related]
18. The use of a wild-type dihydrofolate reductase-encoding cDNA as a dominant selectable marker and induction of expression by methotrexate. Lo KM, Lynch CA, Gillies SD. Gene; 1992 Nov 16; 121(2):365-9. PubMed ID: 1446834 [Abstract] [Full Text] [Related]
19. Comparison of the expression of a mutant dihydrofolate reductase under control of different internal promoters in retroviral vectors. Li M, Hantzopoulos PA, Banerjee D, Zhao SC, Schweitzer BI, Gilboa E, Bertino JR. Hum Gene Ther; 1992 Aug 16; 3(4):381-90. PubMed ID: 1525211 [Abstract] [Full Text] [Related]
20. Development of an amphotropic, high-titer retrovirus vector expressing the dihydrofolate reductase gene and conferring methotrexate resistance. Narayanan R, Jastreboff MM, Bertino JR. Gene; 1986 Aug 16; 48(1):71-80. PubMed ID: 3030894 [Abstract] [Full Text] [Related] Page: [Next] [New Search]